{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:53:20Z","timestamp":1782492800177,"version":"3.54.5"},"reference-count":32,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W006677\/1"],"award-info":[{"award-number":["MR\/W006677\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220283\/Z\/20\/Z"],"award-info":[{"award-number":["220283\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,26]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Infections are a major cause of morbidity and mortality among individuals with haematological cancers, but the duration of elevated risk in long-term survivors remains uncertain. Although previous attempts to summarise the existing literature on this topic would have been hampered by the sheer volume of studies on cancer and all-cause infections, emerging artificial intelligence tools now offer the ability to streamline the screening process, allowing for broader and more comprehensive reviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols guidelines. Eligible studies will include original observational data reporting long-term (\u22651 year follow-up from diagnosis) infection-related outcomes in haematological cancer survivors compared with a general or cancer-free population. Screening will be supported by ASReview, an artificial intelligence-based tool for abstract prioritisation. An internal validation step will be conducted by comparing artificial intelligence-assisted screening results with manual review performed by two independent researchers on a subset of abstracts. The primary outcomes of infection incidence and infection mortality will be summarised by type of infection, type of haematological cancer and time since cancer diagnosis. Information on anti-cancer treatments received will also be described. Data synthesis will be mostly narrative due to the broad scope of the review, though meta-analyses will be performed in cases where studies are sufficiently homogenous. Risk of bias will be assessed using the Newcastle-Ottawa Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval is not applicable to this study. The results of the review will be disseminated to clinical audiences and submitted to a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420251047091.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114803","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:56:03Z","timestamp":1773870963000},"page":"e114803","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligence-based methods"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5576-0135","authenticated-orcid":false,"given":"William","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Forbes","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hazell","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Funston","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"},{"name":"University College London Cancer Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Bhaskaran","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-2526","authenticated-orcid":false,"given":"Helena","family":"Carreira","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026062609364558000_16.3.e114803.1","unstructured":"World Health Organization . Haematolymphoid tumours: WHO classification of tumours. 5th edn. Lyon, France: International Agency for Research on Cancer, 2022."},{"key":"2026062609364558000_16.3.e114803.2","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026062609364558000_16.3.e114803.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30186-9"},{"key":"2026062609364558000_16.3.e114803.4","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"key":"2026062609364558000_16.3.e114803.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"2026062609364558000_16.3.e114803.6","unstructured":"Observatory GC . Cancer today united kingdom factsheet 2022. 2025. Available: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/826-united-kingdom-fact-sheet.pdf"},{"key":"2026062609364558000_16.3.e114803.7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2018.07.003","article-title":"Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long term follow-up care","volume":"33","author":"Damlaj","year":"2019","journal-title":"Blood Rev"},{"key":"2026062609364558000_16.3.e114803.8","doi-asserted-by":"crossref","unstructured":"The Lancet Haematology . Reducing infection risk in patients with blood cancers. Lancet Haematol 2024;11. doi:10.1016\/S2352-3026(24)00224-2","DOI":"10.1016\/S2352-3026(24)00224-2"},{"key":"2026062609364558000_16.3.e114803.9","doi-asserted-by":"crossref","first-page":"103896","DOI":"10.1016\/j.critrevonc.2022.103896","article-title":"Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology","volume":"181","author":"Shah","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026062609364558000_16.3.e114803.10","doi-asserted-by":"crossref","first-page":"100656","DOI":"10.1016\/j.eclinm.2020.100656","article-title":"Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data","volume":"29\u201330","author":"Carreira","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2026062609364558000_16.3.e114803.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4"},{"key":"2026062609364558000_16.3.e114803.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072254","article-title":"Artificial intelligence in systematic reviews: promising when appropriately used","volume":"13","author":"van Dijk","year":"2023","journal-title":"BMJ Open"},{"key":"2026062609364558000_16.3.e114803.13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s42256-020-00287-7","article-title":"An open source machine learning framework for efficient and transparent systematic reviews","volume":"3","author":"van de Schoot","year":"2021","journal-title":"Nat Mach Intell"},{"key":"2026062609364558000_16.3.e114803.14","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2026062609364558000_16.3.e114803.15","unstructured":"World Health Organization . International classification of diseases for oncology. 3rd edn. 2013."},{"key":"2026062609364558000_16.3.e114803.16","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1424"},{"key":"2026062609364558000_16.3.e114803.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)91524-7"},{"key":"2026062609364558000_16.3.e114803.18","doi-asserted-by":"crossref","DOI":"10.1177\/1178122X17731772","article-title":"Viral Causes of Lymphoma: The History of Epstein-Barr Virus and Human T-Lymphotropic Virus 1","volume":"8","author":"Esau","year":"2017","journal-title":"Virology (Auckl)"},{"key":"2026062609364558000_16.3.e114803.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"2026062609364558000_16.3.e114803.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2031"},{"key":"2026062609364558000_16.3.e114803.21","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9070543","article-title":"Mechanisms of Oncogenesis by HTLV-1 Tax","volume":"9","author":"Mohanty","year":"2020","journal-title":"Pathogens"},{"key":"2026062609364558000_16.3.e114803.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X"},{"key":"2026062609364558000_16.3.e114803.23","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epidemiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani","year":"2020","journal-title":"Lancet HIV"},{"key":"2026062609364558000_16.3.e114803.24","unstructured":"ASReview . Automated systematic review. 2023. Available: https:\/\/asreview.nl"},{"key":"2026062609364558000_16.3.e114803.25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.22.00230","article-title":"A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer Survivors","volume":"41","author":"Chehab","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026062609364558000_16.3.e114803.26","doi-asserted-by":"crossref","unstructured":"Laulund S , Visfeldt J , Klinken L . Patho-anatomical studies in patients dying of AIDS. Acta Pathol Microbiol Immunol Scand A. 1986;94:201\u201321. doi:10.1111\/j.1699-0463.1986.tb02986.x","DOI":"10.1111\/j.1699-0463.1986.tb02986.x"},{"key":"2026062609364558000_16.3.e114803.27","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181813592"},{"key":"2026062609364558000_16.3.e114803.28","unstructured":"O\u2019Connell D , Peterson J , Welch V , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2021. Available: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2026062609364558000_16.3.e114803.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2026062609364558000_16.3.e114803.30","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2026062609364558000_16.3.e114803.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2026062609364558000_16.3.e114803.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:42:34Z","timestamp":1782492154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,18]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-114803"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114803","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}